Have you seen our latest case study? In this blinded real-life example, a pure-play gene therapy client whose product was just being spun out of academia brought DHC into the process to provide guidance over the long-term, conceptualizing and building a development process that would stand up to the challenges of each future trial phase and into commercial production. Check it out here.
accelerating
cell & gene therapies
through unmatched expertise
Services
We apply pharmaceutical industry best practices to the unique challenges of the Cell and Gene Therapy (C>) field. Our team can help you with a wide range of needs, spanning from high level corporate strategy development to detailed technical implementation.
We have a dozen commonly-requested services, listed below.
During 2020, we released 20 case studies to provide concrete examples of how our expertise can support your business. In 2021 we added two additional case studies to the bank. Both of them (Remediation of CRL issues for BLA resubmission, and Embedded early for de novo support) are applicable to six of our twelve service areas. See all case studies in one place here.
- Quantitative modeling
- CMO selection
- Technology transfer
- Facility design
- Failure analysis
- Comparability studies
- Process codification
- Process evaluation
- Process dev planning
- Method development
- Specification setting
- Method transfer
- Qualification & validation
- Remediation
- Comparability testing
- QMS design and strategy
- QMS gap assessment
- Document authoring, review, and revision
- Supplier oversight
- Audits (see flyer below)
- URS development
- Landscape scan & gap analysis
- Custom device design
- Contract manufacturing management
- DHF & DMF development
- Preclinical strategy
- Study design and oversight
- Vendor selection
- Technical writing
- Critical path identification
- Project management
- Strategic project planning
- Stage-gating
- Strategic portfolio
assessment & analysis - Landscape analysis and competitive intelligence
- IP due diligence
- IP strategy
Further proof that a @Phacilitate podcast is always worth a listen!
Interested in sharing your thoughts on https://bit.ly/DHCFDAAAVguidancedoc?
We've set up an email for your comments &/or requests for future proposed draft guidance. Write to: aavguidancedoc@darkhorseconsultinggroup.com
(We can't guarantee a response due to volume, but we'll read 'em all!)
Love seeing this out there! Thanks, @biospace!